Page last updated: 2024-08-26

lysophosphatidic acid and Disease Exacerbation

lysophosphatidic acid has been researched along with Disease Exacerbation in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (27.59)29.6817
2010's16 (55.17)24.3611
2020's5 (17.24)2.80

Authors

AuthorsStudies
Birnberg, A; Chakrabarti, A; Choy, DF; Grimbaldeston, MA; Li, Q; Neighbors, M; Olsson, J; Rosenberger, CM; Sandoval, W; Tew, GW; Verschueren, E; Wong, W; Yang, X1
Damirin, A; Li, A; Li, R; Sun, H; Wang, Y; Yan, Y; Yun, Q; Zhao, P1
Jia, G; Li, Q; Liu, J; Neighbors, M; Sandoval, W; Tew, GW; Wong, WR; Zhu, SJ1
Bai, H; Cao, G; Cui, R; Zhang, Z1
Cao, R; Jiang, H; Liu, S; Min, L; Ning, T; Wang, T; Wang, X; Xu, J; Zhang, Q; Zhang, S; Zhu, S1
Hegedüs, B; Rásó, E; Tímár, J1
Chen, CC; Chen, WM; Huang, YL; Jou, YC; Kanaho, Y; Lee, H; Lin, YC; Lu, KY; Ohbayashi, N; Shen, CH; Shen, TL1
Arsenault, BJ; Bossé, Y; Bouchareb, R; Boulanger, MC; Dahou, A; Hadji, F; Marette, A; Mathieu, P; Messadeq, Y; Mkannez, G; Nsaibia, MJ; Pibarot, P; Tastet, L1
Herrera, M; Losert, W; Parent, CA; Sato, M; Shou, K; Stuelten, CH; Vedham, V; Weiger, MC1
Bao, S; Day, R; Tan, C; Turk, J; Zhao, QD1
Cai, Q; Fan, Q; Xu, Y1
Hwang, YS; Lee, J; Lindholm, PF; Zhang, X1
Choi, JW; Jun, HS; Jung, JY; Li, HY; Oh, YS1
Fukushima, K; Fukushima, N; Honoki, K; Onishi, Y; Takahashi, K; Tsujiuchi, T; Yamasaki, E1
Fishman, DA; Pua, TL; Wang, FQ1
Lee, HY; Mills, GB; Panupinthu, N1
Biessen, EA; Bot, I; Bot, M; David, S; Helms, JB; Lopez-Vales, R; Saulnier-Blache, JS; van Berkel, TJ; van de Lest, CH1
Bekele, R; Brindley, DN; Capatos, D; Samadi, N; Sariahmetoglu, M; Venkatraman, G1
Bascands, JL; Buffin-Meyer, B; Klein, J; Miravete, M; Schanstra, JP1
Antonaci, S; Dituri, F; Giannelli, G; Lupo, L; Mazzocca, A; Quaranta, M1
Bastos, LG; Leve, F; Marcondes, TG; Morgado-Díaz, JA; Rabello, SV; Tanaka, MN1
Goldsmith, PK; Heger, CD; Kelly, K; Lake, R; Merino, M; Raffeld, M; Ward, Y; Yin, JJ1
Angeli, V; Fisher, EA; Liu, J; Llodrá, J; Randolph, GJ; Trogan, E1
Hirano, K; Koike, T; Satouchi, K; Tanaka, T; Tokumura, A; Tsutsui, H1
Gupta, GP; Massagué, J1
Bordet, JC; Boucharaba, A; Clézardin, P; Grès, S; Guglielmi, J; Peyruchaud, O; Saulnier-Blache, JS; Serre, CM1
Bordet, JC; Boucharaba, A; Clézardin, P; Guglielmi, J; Peyruchaud, O; Serre, CM1
Hashimoto, K; Kimura, T; Morishige, K; Ogata, S; Sakata, M; Sawada, K; Shimizu, S; Tahara, M; Tasaka, K1
Mills, GB; Murph, M1

Reviews

8 review(s) available for lysophosphatidic acid and Disease Exacerbation

ArticleYear
The Role of Lysophosphatidic Acid Receptors in Ovarian Cancer: A Minireview.
    Critical reviews in eukaryotic gene expression, 2020, Volume: 30, Issue:3

    Topics: AMP-Activated Protein Kinases; Cell Transformation, Neoplastic; Chemokine CXCL1; Cyclin D1; Cyclooxygenase 2; Cytoskeletal Proteins; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukins; Lysophospholipids; Ovarian Neoplasms; Peptide Fragments; Receptors, Lysophosphatidic Acid; Signal Transduction; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A

2020
The role of lipid signaling in the progression of malignant melanoma.
    Cancer metastasis reviews, 2018, Volume: 37, Issue:2-3

    Topics: Animals; Arachidonic Acid; Cyclooxygenase 2; Disease Progression; Endocannabinoids; Genetic Predisposition to Disease; Humans; Lipid Metabolism; Lysophospholipids; Melanoma; Metabolic Networks and Pathways; Phosphatidylinositol 3-Kinases; Phospholipases; Phosphoric Diester Hydrolases; Prenylation; Prostaglandins; Receptors, Lysophosphatidic Acid; Signal Transduction

2018
Roles of LPA in ovarian cancer development and progression.
    Future oncology (London, England), 2009, Volume: 5, Issue:10

    Topics: Animals; Cell Transformation, Neoplastic; Disease Progression; Female; Humans; Lysophospholipids; Ovarian Neoplasms; Signal Transduction

2009
Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
    British journal of cancer, 2010, Mar-16, Volume: 102, Issue:6

    Topics: Animals; Breast Neoplasms; Cell Transformation, Neoplastic; Disease Progression; Female; Humans; Lysophospholipids; Mice; Models, Biological; Multienzyme Complexes; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases; Receptors, Lysophosphatidic Acid; Signal Transduction

2010
Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
    Biochimie, 2011, Volume: 93, Issue:1

    Topics: Animals; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Intercellular Signaling Peptides and Proteins; Lysophospholipids; Male; Mice; Multienzyme Complexes; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phosphatidate Phosphatase; Phosphodiesterase I; Phospholipase D; Phosphoric Diester Hydrolases; Pyrophosphatases; Signal Transduction; Sphingosine

2011
[Tubulo-interstitial fibrosis: an emerging major health problem].
    Medecine sciences : M/S, 2011, Volume: 27, Issue:1

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Hypoxia; Chemokines; Cytokines; Disease Progression; Extracellular Matrix; Fibroblasts; Humans; Incidence; Intercellular Signaling Peptides and Proteins; Kallikrein-Kinin System; Kidney; Kidney Failure, Chronic; Lysophospholipids; Macrophages; Mice; Models, Biological; Morbidity; Myoblasts; Nephritis, Interstitial; Proteinuria; Renin-Angiotensin System

2011
Platelets and metastasis revisited: a novel fatty link.
    The Journal of clinical investigation, 2004, Volume: 114, Issue:12

    Topics: Blood Platelets; Bone and Bones; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Humans; Lysophospholipids; Models, Biological; Neoplasm Metastasis; Neovascularization, Pathologic; Osteolysis; Ovarian Neoplasms

2004
Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression.
    Expert reviews in molecular medicine, 2007, Oct-15, Volume: 9, Issue:28

    Topics: Disease Progression; Drug Delivery Systems; Lysophospholipids; Neoplasms; Signal Transduction; Sphingosine; Treatment Outcome

2007

Trials

1 trial(s) available for lysophosphatidic acid and Disease Exacerbation

ArticleYear
Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis.
    Journal of lipid research, 2023, Volume: 64, Issue:6

    Topics: Biomarkers; Disease Progression; Humans; Idiopathic Pulmonary Fibrosis; Lysophospholipids

2023

Other Studies

20 other study(ies) available for lysophosphatidic acid and Disease Exacerbation

ArticleYear
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease.
    BMC pulmonary medicine, 2021, Sep-23, Volume: 21, Issue:1

    Topics: Aged; Biomarkers; Disease Progression; Female; Humans; Logistic Models; Lysophospholipids; Male; Middle Aged; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Severity of Illness Index

2021
LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
    Medical oncology (Northwood, London, England), 2022, Jan-04, Volume: 39, Issue:2

    Topics: Animals; Biomarkers, Tumor; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Humans; Immunohistochemistry; Lysophospholipids; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Ovarian Neoplasms; Receptors, Lysophosphatidic Acid; Signal Transduction

2022
Lysophosphatidic acid mediated PI3K/Akt activation contributed to esophageal squamous cell cancer progression.
    Carcinogenesis, 2021, 04-30, Volume: 42, Issue:4

    Topics: Animals; Cell Line, Tumor; Cell Lineage; Cell Movement; Cell Proliferation; Disease Progression; Esophageal Squamous Cell Carcinoma; Heterografts; Humans; Lysophospholipids; Mice; Phosphoric Diester Hydrolases; Proto-Oncogene Proteins c-akt; Receptors, Lysophosphatidic Acid

2021
LPA
    Biochimica et biophysica acta. Molecular and cell biology of lipids, 2018, Volume: 1863, Issue:10

    Topics: Animals; Cell Line, Tumor; Disease Progression; Eukaryotic Initiation Factor-2; Humans; Lymphangiogenesis; Lymphatic Metastasis; Lysophospholipids; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphoric Diester Hydrolases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; Signal Transduction; Vascular Endothelial Growth Factor C

2018
Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis.
    European heart journal, 2019, 05-01, Volume: 40, Issue:17

    Topics: Animals; Aortic Valve; Aortic Valve Stenosis; Apolipoprotein B-100; Blood Platelets; Calcinosis; Disease Progression; Humans; Integrin beta3; Lysophospholipids; Mice; Microscopy, Electron, Scanning; Osteogenesis; Phosphoric Diester Hydrolases; Platelet Membrane Glycoprotein IIb

2019
Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Disease Progression; Epidermal Growth Factor; Female; Humans; Lysophospholipids; Neoplasm Metastasis; Phenotype; Tumor Stem Cell Assay

2013
Group VIA phospholipase A2 mediates enhanced macrophage migration in diabetes mellitus by increasing expression of nicotinamide adenine dinucleotide phosphate oxidase 4.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:4

    Topics: Animals; Atherosclerosis; Cell Movement; Cells, Cultured; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Group VI Phospholipases A2; Hydrogen Peroxide; Lysophospholipids; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 4; NADPH Oxidases; Oligonucleotides, Antisense; Receptors, LDL; Signal Transduction; Stress, Physiological; Time Factors; Transfection; Up-Regulation

2014
FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
    Oncotarget, 2015, Sep-29, Volume: 6, Issue:29

    Topics: Adaptor Proteins, Signal Transducing; Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cystadenocarcinoma, Serous; Disease Progression; Dose-Response Relationship, Drug; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphoproteins; RNA Interference; Signal Transduction; Transcription Factors; Transcription, Genetic; YAP-Signaling Proteins

2015
Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Extracellular Matrix; Heterografts; Humans; Lysophospholipids; Male; Neoplasm Invasiveness; NF-kappa B; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; rhoA GTP-Binding Protein; Signal Transduction

2016
Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
    Kidney international, 2017, Volume: 91, Issue:6

    Topics: Animals; Cell Line; Diabetes Mellitus; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Glycogen Synthase Kinase 3 beta; Isoxazoles; Kidney Cortex; Lysophospholipids; Male; Mice, Inbred C57BL; Phosphoric Diester Hydrolases; Phosphorylation; Propionates; Receptors, Lysophosphatidic Acid; RNA Interference; Signal Transduction; Smad2 Protein; Smad3 Protein; Sterol Regulatory Element Binding Protein 1; Time Factors; Transfection; Transforming Growth Factor beta

2017
Lysophosphatidic acid signaling via LPA
    Experimental cell research, 2017, 03-01, Volume: 352, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Cisplatin; Disease Progression; Drug Therapy, Combination; Humans; Lysophospholipids; Matrix Metalloproteinase 2; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured

2017
Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation.
    The American journal of pathology, 2010, Volume: 176, Issue:6

    Topics: Acyltransferases; Animals; Atherosclerosis; Carotid Arteries; Diet; Disease Progression; Gene Expression Profiling; Group VI Phospholipases A2; Homeostasis; Humans; Lysophospholipids; Male; Mice; Mice, Knockout; Molecular Sequence Data; Receptors, LDL

2010
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.
    Hepatology (Baltimore, Md.), 2011, Sep-02, Volume: 54, Issue:3

    Topics: Actins; Carcinoma, Hepatocellular; Cell Differentiation; Disease Progression; Fibroblasts; Humans; Liver Neoplasms; Lysophospholipids; Myofibroblasts; Phosphoric Diester Hydrolases

2011
Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
    European journal of pharmacology, 2011, Dec-05, Volume: 671, Issue:1-3

    Topics: Adherens Junctions; Caco-2 Cells; Cell Movement; Colonic Neoplasms; Disease Progression; Focal Adhesion Kinase 1; Focal Adhesions; Humans; Lysophospholipids; Phenotype; Protein Kinases; Proto-Oncogene Proteins pp60(c-src); rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Stress Fibers

2011
LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
    Cancer research, 2011, Dec-01, Volume: 71, Issue:23

    Topics: Antigens, CD; Cell Line, Tumor; Disease Progression; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Protein alpha Subunits, G12-G13; Guanosine Triphosphate; Humans; Lysophospholipids; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Prostatic Neoplasms; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; rhoA GTP-Binding Protein; Signal Transduction

2011
Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, Aug-10, Volume: 101, Issue:32

    Topics: Animals; Aorta, Thoracic; Apolipoproteins E; Arteriosclerosis; Cell Movement; Disease Progression; Endothelium, Vascular; Female; Kinetics; Lipids; Lysophospholipids; Male; Mice; Mice, Knockout; Monocytes; Platelet Activating Factor; Transplantation, Homologous

2004
Quantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule.
    Journal of lipid research, 2004, Volume: 45, Issue:11

    Topics: Animals; Cattle; Chromatography, Thin Layer; Disease Progression; Dose-Response Relationship, Drug; Egg White; Lysophospholipids; Mass Spectrometry; Models, Chemical; Phosphates; Plant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Wound Healing; Zinc

2004
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
    The Journal of clinical investigation, 2004, Volume: 114, Issue:12

    Topics: Animals; Blood Platelets; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Cricetinae; Culture Media; Cytokines; Disease Progression; Dose-Response Relationship, Drug; Doxycycline; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Interleukin-6; Interleukin-8; Ki-67 Antigen; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogens; Models, Biological; Neoplasm Metastasis; Osteoclasts; Osteolysis; Phospholipase D; Platelet Activation; Platelet Aggregation; Reverse Transcriptase Polymerase Chain Reaction; RNA; Time Factors; Transfection

2004
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Jun-20, Volume: 103, Issue:25

    Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytokines; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Lysophospholipids; Mice; Neoplasm Metastasis; Osteoclasts; Propionates; Receptors, Lysophosphatidic Acid

2006
Geranylgeranylacetone inhibits ovarian cancer progression in vitro and in vivo.
    Biochemical and biophysical research communications, 2007, Apr-27, Volume: 356, Issue:1

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Disease Progression; Diterpenes; Dose-Response Relationship, Drug; Female; Humans; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Phosphorylation; ras Proteins; Time Factors; Xenograft Model Antitumor Assays

2007